Product Information
CEFEPIME HCL 1 GM VIAL is a generic product labeled by Apotex Corp., priced at $3.7308 per EA under NDC 60505614404. Its NADAC has been published 122 times since Apr 17, 2024.
FDA first approved this application on Feb 1, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/1
Manufacturer
Apotex Corp.NDC
60505614404
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/20/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203704FDA Approved
2/1/2016
TE Code
AP
On Market Since
11/14/2017
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 1 GM VIAL has been published 122 times since Apr 17, 2024, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7308 per EA |
|---|---|
| All-time high | $3.9442 (Nov 13, 2024) |
| All-time low | $3.3241 (Apr 23, 2025) |
| 52-week high | $3.7308 |
| 52-week low | $3.7308 |
| Median price | $3.7308 |
| Average price | $3.6480 |
| Largest weekly change | -10.4% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 1 GM VIAL, manufactured by Apotex Corp., is $3.7308 per EA (NDC 60505614404), effective Aug 12, 2026.
How has the price of CEFEPIME HCL 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 1 GM VIAL has risen 3.4%. It has been tracked across 122 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 1 GM VIAL?
Since Apr 17, 2024, the NADAC for CEFEPIME HCL 1 GM VIAL has ranged from a low of $3.3241 (Apr 23, 2025) to a high of $3.9442 (Nov 13, 2024), with a median of $3.7308 per EA.
Are there cheaper alternatives to CEFEPIME HCL 1 GM VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFEPIME HCL 1 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFEPIME HCL 1 GM VIAL?
CEFEPIME HCL 1 GM VIAL (NDC 60505614404) is labeled by Apotex Corp., and CMS classifies it as a generic product.